Provided by Tiger Trade Technology Pte. Ltd.

Janux Therapeutics, Inc.

16.96
-0.3200-1.85%
Post-market: 16.960.00000.00%17:34 EDT
Volume:837.46K
Turnover:14.19M
Market Cap:1.04B
PE:-10.32
High:17.35
Open:17.20
Low:16.76
Close:17.28
52wk High:35.34
52wk Low:12.12
Shares:61.14M
Float Shares:42.53M
Volume Ratio:1.11
T/O Rate:1.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6429
EPS(LYR):-1.8336
ROE:-10.70%
ROA:-8.80%
PB:1.12
PE(LYR):-9.25

Loading ...

H.C. Wainwright Keeps Their Buy Rating on Janux Therapeutics Inc (JANX)

TIPRANKS
·
Yesterday

Is First Patient Dosed Altering The Investment Case For Janux Therapeutics (JANX)?

Simply Wall St.
·
Yesterday

Janux’s New Prostate Cancer Combo Trial: What Early Signals Could Mean for JANX

TIPRANKS
·
Sep 18

Janux Doses First Patient in Phase 1 Trial of Janx013 in Metastatic Prostate Cancer

Reuters
·
Sep 14

Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of Janx013

THOMSON REUTERS
·
Sep 14

Janux’s JANX014 Prostate Cancer Trial Advances, Keeping Early-Stage Upside in Play

TIPRANKS
·
Sep 04

Brinker, Whirlpool, Q32 Bio, Pulte, Janux Trending With Analysts

TIPRANKS
·
Aug 29

Janux Therapeutics upgraded to Outperform from Peer Perform at Wolfe Research

TIPRANKS
·
Aug 24

Janus Living Prices Share Offering

MT Newswires Live
·
Aug 11

RBC Adjusts Price Target on Janux Therapeutics to $34 From $30, Maintains Outperform Rating

MT Newswires Live
·
Aug 10

Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Janux Therapeutics Inc (JANX) and Entrada Therapeutics Inc (TRDA)

TIPRANKS
·
Aug 10

Analyst Maintains Buy on Janux Therapeutics, Keeps $60 Price Target Unchanged on Strong Balance Sheet and Clinical Differentiation

TIPRANKS
·
Aug 08

Janux Therapeutics is Maintained at Buy by Guggenheim

Dow Jones
·
Aug 08

Janux Therapeutics price target lowered to $55 from $58 at Guggenheim

TIPRANKS
·
Aug 07

Janux Therapeutics Inc (JANX) Receives a Sell from Barclays

TIPRANKS
·
Aug 07

Analysts’ Top Healthcare Picks: Lyell Immunopharma (LYEL), Janux Therapeutics Inc (JANX)

TIPRANKS
·
Aug 07

Janux Therapeutics Q2 EPS $(0.35) Beats $(0.38) Estimate, Sales $10.267M Miss $16.493M Estimate

Benzinga Earnings
·
Aug 07

Janux Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Janux Therapeutics reports Q2 EPS (35c), consensus (29c)

TIPRANKS
·
Aug 07

Janux Therapeutics Q2 Basic EPS USD -0.35

THOMSON REUTERS
·
Aug 07